Tonix CEO Dr. Seth Lederman said he thinks his company’s live virus platform could offer the long-lasting, transmission-blocking protection against COVID-19 that the mRNA vaccines so far haven’t been able to.
Tonix CEO Dr. Seth Lederman said he thinks his company’s live virus platform could offer the long-lasting, transmission-blocking protection against COVID-19 that the mRNA vaccines so far haven’t been able to.

We receive an extra bonus for reaching 100 first-time donors. If you’ve never given before, now is the time.
We'll send a verification code to %EMAIL%.
Get the best of The New Bedford Light directly in your email inbox.
Sending to: